SCHEMBL1675247

SCHEMBL1675247

CN(CC1CCCCO1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 17/20 0.62
CYP1A2 P05177 3/20 0.62
CYP3A4 P08684 3/20 0.62
CYP2D6 P10635 3/20 0.62
CYP2C19 P33261 3/20 0.62
ALDH1A1 P00352 2/20 0.62
LMNA P02545 2/20 0.62
TSHR P16473 2/20 0.62
MAPK1 P28482 2/20 0.62
HSD17B10 Q99714 2/20 0.62
HIF1A Q16665 1/20 0.62
CLK1 P49759 15/20 0.60
CLK2 P49760 14/20 0.60
DYRK1A Q13627 14/20 0.60
DYRK1B Q9Y463 14/20 0.60
CLK3 P49761 11/20 0.60
KDM4E B2RXH2 1/20 0.58
CYP2C9 P11712 1/20 0.58
HPGD P15428 1/20 0.58
CDK2 P24941 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675214 0.97 CLK4 (0.64) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1675266 0.89 CLK4 (0.63) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1675366 0.86 CLK4 (0.67) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1675075 0.80 CLK4 (0.77) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1675332 0.78 CLK4 (0.94) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1675074 0.78 CLK4 (0.74) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1675316 0.76 CLK4 (0.69) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1675369 0.75 CLK4 (1.00) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1675197 0.75 CLK4 (1.00) CLK4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1675200 0.75 CLK4 (1.00) CLK4CYP1A2CYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed